GeneDx to Participate in 44th Annual Cowen Health Care Conference
STAMFORD, Conn., Feb. 26, 2024 (GLOBE NEWSWIRE) — GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic […]
Talkspace to Present at the Barclays 26th Annual Global Healthcare Conference
NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) — Talkspace (Nasdaq: TALK), a leading behavioral healthcare company, today announced that management […]
Clover Health to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
FRANKLIN, Tenn., Feb. 26, 2024 (GLOBE NEWSWIRE) — Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), […]
EverQuote Announces Fourth Quarter and Full Year 2023 Financial Results
Fourth Quarter Revenue of $55.7 million Fourth Quarter Variable Marketing Margin of $20.7 million Full Year Revenue of $287.9 million […]
American Oncology Network to Present at Cowen Annual Health Care Conference
FORT MYERS, Fla., Feb. 26, 2024 (GLOBE NEWSWIRE) — American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), one of […]
Asure Announces Fourth Quarter and Full Year 2023 Results
Reports Full Year Revenues of $119.1 million, up 24% from Prior Year Net loss of $9.2 million, an improvement of […]
Robinhood Markets, Inc. to Present at the JMP Securities Technology Conference on March 4, 2024
MENLO PARK, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced that it will […]
Varonis to Present at March Investor Conferences
NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) — Varonis Systems, Inc. (Nasdaq: VRNS), a leader in data security, announced its […]
Lyell Immunopharma Announces Participation in March Investor Conferences
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company […]
IO Biotech to Present at 44th Annual Cowen Health Care Conference
NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic […]
